Edgestream Partners, L.P. Neurocrine Biosciences Inc Transaction History

Edgestream Partners, L.P.

$3.32 Billion
Q3 2025

A detailed history of Edgestream Partners, L.P. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Edgestream Partners, L.P. holds 3,959 shares of NBIX stock, worth $573,500. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,959

Previous 73,604 94.62%

Holding current value

$573,500

Previous $9.25 Million 94.0%

% of portfolio

0.02%

Previous 0.27%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$123.98 - $146.67 $8.63 Million - $10.2 Million	-69,645 Reduced 94.62%	3,959 $555,000
Q2 2025 Aug 13, 2025	BUY	$87.54 - $128.18 $6.44 Million - $9.43 Million	73,604 New	73,604 $9.25 Million
Q4 2024 Feb 06, 2025	BUY	$111.62 - $139.44 $815,718 - $1.02 Million	7,308 Added 138.78%	12,574 $1.72 Million
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $4.46 Million - $5.96 Million	-38,928 Reduced 88.08%	5,266 $606,000
Q2 2024 Aug 09, 2024	BUY	$130.86 - $143.19 $2.64 Million - $2.89 Million	20,189 Added 84.1%	44,194 $6.08 Million

Q1 2024 May 10, 2024	BUY	$130.4 - $143.74 $1.3 Million - $1.44 Million	10,002 Added 71.43%	24,005 $3.31 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $1.27 Million - $1.59 Million	11,957 Added 584.41%	14,003 $1.85 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $1 Million - $1.25 Million	-10,657 Reduced 83.89%	2,046 $230,000
Q2 2023 Aug 10, 2023	SELL	$89.53 - $104.87 $2.2 Million - $2.58 Million	-24,569 Reduced 65.92%	12,703 $1.2 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $1.8 Million - $2.35 Million	19,118 Added 105.31%	37,272 $3.77 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $999,432 - $1.19 Million	9,365 Added 106.55%	18,154 $2.17 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $333,148 - $390,272	3,620 Added 70.03%	8,789 $933,000
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $1.59 Million - $2.1 Million	-20,954 Reduced 80.21%	5,169 $504,000
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $1.44 Million - $1.89 Million	-19,933 Reduced 43.28%	26,123 $2.45 Million
Q4 2021 Feb 15, 2022	BUY	$79.65 - $106.22 $3.67 Million - $4.89 Million	46,056 New	46,056 $3.92 Million
Q2 2021 Aug 10, 2021	SELL	$89.43 - $102.27 $792,081 - $905,805	-8,857 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$87.57 - $119.4 $775,607 - $1.06 Million	8,857 New	8,857 $861,000

Others Institutions Holding NBIX

# of Institutions

729

Shares Held

102M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Neurocrine Biosciences Inc Transaction History